Latest Safety News

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Lanthanein Resources has completed diamond drilling at its Lady Grey Project, targeting a significant EM conductor plate aligned with gold anomalies. Approval for further drilling under a higher-grade anomaly sets the stage for potential resource expansion.

PARKD has inked a pivotal five-year exclusive licensing agreement with Fielders, a BlueScope Steel division, to commercialise its innovative MDSB® and MDSS® products in Australia and explore international expansion.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.

Sparc Technologies has secured a fourth trial agreement with BHP Mitsubishi Alliance to test its graphene-enhanced ecosparc® coating in harsh mining conditions, aiming to validate its anti-corrosive performance against market leaders.

AdAlta Limited is accelerating its 'East to West' cellular immunotherapy strategy, aiming to bridge Asian innovation with Western clinical development and manufacturing to target solid cancers. The company plans to secure three assets by the end of 2025 and initiate clinical trials, positioning itself as a leader in this emerging market.

Actinogen Medical has published a peer-reviewed article confirming the efficacy of a 10 mg daily dose of Xanamem for treating neurological conditions, reinforcing its ongoing clinical trials in Alzheimer's and depression.

Lindian Resources has awarded a $1.3 million contract to Mota-Engil for the construction of a critical access road at its Kangankunde Rare Earths Project in Malawi, marking a key milestone in project development and local infrastructure enhancement.

WA Kaolin Limited has announced a fully underwritten pro-rata accelerated non-renounceable rights offer to raise approximately $7 million, aiming to bolster working capital and support production ramp-up at its Wickepin operations.

WA Kaolin Ltd has launched a fully underwritten A$7 million entitlement offer to fund a critical ramp-up in production following successful operational upgrades. With strong forward orders and supportive major shareholders, the company aims to achieve positive cash flow and expand its market footprint.

WA Kaolin Limited is raising A$7 million through a fully underwritten entitlement offer to support its sales ramp-up and working capital needs, following a successful upgrade to its classifier project that enhances production capabilities.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.